HUIJING ZHANG

Dr. HUIJING ZHANG


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
HZHUIJING ZHANG
HUIJING ZHANG
YZYi-Ning Zhang
Yi-Ning Zhang
HZHuan Zhou
Huan Zhou
LGLin Guan
Lin Guan
YLYue Li
Yue Li
MSMing-Jun Sun
Ming-Jun Sun

30 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
MYMeiqi Yang
Meiqi Yang
MSMingjun Sun
Mingjun Sun
HZHUIJING ZHANG
HUIJING ZHANG
Worldwide, colorectal cancer (CRC) ranks as the third most common malignancy, and the second most deadly with nearly one million attributable deaths in 2020. Metastatic disease is present in nearly 25% of newly diagnosed CRC, and despite advances in chemotherapy, less than 20% will remain alive at 5 years. Epigenetic change plays a key role in the epithelial-to-mesenchymal transition (EMT), which is a crucial phenotype for metastasis and mainly includes DNA methylation, non-coding RNAs (ncRNAs), and N6-methyladenosine (m6A) RNA, seemingly valuable biomarkers in CRCs. For ncRNAs, there exists a “molecular sponge effect” between long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs). The detection of exosomes is a novel method in CRC monitoring, especially for predicting metastasis. There is a close relationship between exosomes and EMT in CRCs. This review summarizes the close relationship between epigenetic changes and EMT in CRCs and emphasizes the crucial function of exosomes in regulating the EMT process.